Literature DB >> 24141292

Obstructive sleep apnea syndrome: complaints and housing characteristics in a population in the United States.

Khalil Ansarin1, Leyla Sahebi, Siamak Sabur.   

Abstract

CONTEXT AND OBJECTIVE Obstructive sleep apnea syndrome (OSAS) is one of the leading causes of morbidity and mortality in adults. Early detection of the disorder and discovery of risk factors through standardized questionnaires will lead to reduction of the OSAS burden. The main aim of this study was to estimate the prevalence of OSAS symptoms and examine their association with housing characteristics. DESIGN AND SETTING Cross-sectional study at a medical school. METHODS Demographic, housing and body measurement data on 5,545 individuals aged 16 years and over of various races were selected from the National Health and Nutrition Examination Survey. We analyzed the probability of OSAS based on habitual snoring combined with daytime sleepiness and/or witnessed apnea. Univariate and multiple linear regression were used. RESULTS 9.8% of the men and 6.9% of the women reported symptoms suggestive of OSAS (habitual snoring, daytime sleepiness and/or apnea). The following prevalences of symptoms were found among males and females respectively: frequent snoring 35.1%, 22.3%, excessive daytime sleepiness 6.4%, 3.4% and frequent apnea 14.9%, 20.6%. Using multiple linear regression, OSAS symptoms were correlated with gender, age, body mass index (BMI), marital status and education. Regarding housing characteristics, mildew or musty smell and pets in the environment were associated with a high probability of OSAS. CONCLUSION OSAS symptoms were more prevalent than in developing countries. The environment was an important risk factor, but environmental factors are easier to control and manage than other variables like BMI or socioeconomic status.

Entities:  

Mesh:

Year:  2013        PMID: 24141292     DOI: 10.1590/1516-3180.2013.1314451

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  8 in total

1.  Development of the National Healthy Sleep Awareness Project Sleep Health Surveillance Questions.

Authors:  Timothy I Morgenthaler; Janet B Croft; Leslie C Dort; Lauren D Loeding; Janet M Mullington; Sherene M Thomas
Journal:  J Clin Sleep Med       Date:  2015-09-15       Impact factor: 4.062

2.  Prevalence of Sleep Disordered Breathing Symptoms and Risk Factors for Chronic Diseases: Are There Differences in Countries of High and Low Income?

Authors:  Leonardo Roever; Stuart F Quan
Journal:  Sleep       Date:  2015-09-01       Impact factor: 5.849

Review 3.  SEDASYS(®), airway, oxygenation, and ventilation: anticipating and managing the challenges.

Authors:  Basavana Gouda Goudra; Preet Mohinder Singh; Vinay Chandrasekhara
Journal:  Dig Dis Sci       Date:  2014-01-08       Impact factor: 3.199

Review 4.  Socioeconomic Position and Excessive Daytime Sleepiness: A Systematic Review of Social Epidemiological Studies.

Authors:  Imene Bendaoud; Faustin Armel Etindele Sosso
Journal:  Clocks Sleep       Date:  2022-05-16

5.  Sleep complaints in the Brazilian population: Impact of socioeconomic factors.

Authors:  Camila Hirotsu; Lia Bittencourt; Silverio Garbuio; Monica Levy Andersen; Sergio Tufik
Journal:  Sleep Sci       Date:  2014-09-26

6.  Healthy-Sustainable Housing Index: A Pilot Study to Link Architecture and Public Health in a Semi-Urban Community in Mexico.

Authors:  Pamela Zúñiga-Bello; Astrid Schilmann; Eunice Félix-Arellano; Gerardo Gama-Hernández; Urinda Alamo-Hernández
Journal:  Int J Environ Res Public Health       Date:  2019-01-22       Impact factor: 3.390

Review 7.  The Prevalence of Sleep Apnea in Iran: a Systematic Review and Meta-Analysis.

Authors:  Mandana Sarokhani; Mitra Goli; Shahin Salarvand; Reza Ghanei Gheshlagh
Journal:  Tanaffos       Date:  2019-01

8.  Predictors of Sleep Apnea in the Canadian Population.

Authors:  Ina van der Spuy; Gaungming Zhao; Chandima Karunanayake; Punam Pahwa
Journal:  Can Respir J       Date:  2018-08-28       Impact factor: 2.409

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.